KR102083253B1 - 열겔화 인공 누액 - Google Patents

열겔화 인공 누액 Download PDF

Info

Publication number
KR102083253B1
KR102083253B1 KR1020197026971A KR20197026971A KR102083253B1 KR 102083253 B1 KR102083253 B1 KR 102083253B1 KR 1020197026971 A KR1020197026971 A KR 1020197026971A KR 20197026971 A KR20197026971 A KR 20197026971A KR 102083253 B1 KR102083253 B1 KR 102083253B1
Authority
KR
South Korea
Prior art keywords
viscosity
composition
present
degreec
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020197026971A
Other languages
English (en)
Korean (ko)
Other versions
KR20190110624A (ko
Inventor
다케시 야마무라
아야카 야마무로
에미 이즈쿠라
모토 기무라
도모히로 오쓰카
Original Assignee
와카모토 세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 와카모토 세이야꾸 가부시끼가이샤 filed Critical 와카모토 세이야꾸 가부시끼가이샤
Priority to KR1020207004982A priority Critical patent/KR102281853B1/ko
Publication of KR20190110624A publication Critical patent/KR20190110624A/ko
Application granted granted Critical
Publication of KR102083253B1 publication Critical patent/KR102083253B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
KR1020197026971A 2017-04-25 2018-04-25 열겔화 인공 누액 Expired - Fee Related KR102083253B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020207004982A KR102281853B1 (ko) 2017-04-25 2018-04-25 열겔화 인공 누액

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JPJP-P-2017-086512 2017-04-25
JP2017086512 2017-04-25
JP2017249891 2017-12-26
JPJP-P-2017-249891 2017-12-26
PCT/JP2018/016854 WO2018199180A1 (ja) 2017-04-25 2018-04-25 熱ゲル化人工涙液

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020207004982A Division KR102281853B1 (ko) 2017-04-25 2018-04-25 열겔화 인공 누액

Publications (2)

Publication Number Publication Date
KR20190110624A KR20190110624A (ko) 2019-09-30
KR102083253B1 true KR102083253B1 (ko) 2020-03-02

Family

ID=63919901

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020197026971A Expired - Fee Related KR102083253B1 (ko) 2017-04-25 2018-04-25 열겔화 인공 누액
KR1020207004982A Expired - Fee Related KR102281853B1 (ko) 2017-04-25 2018-04-25 열겔화 인공 누액

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020207004982A Expired - Fee Related KR102281853B1 (ko) 2017-04-25 2018-04-25 열겔화 인공 누액

Country Status (16)

Country Link
US (2) US10532026B2 (cg-RX-API-DMAC10.html)
EP (1) EP3593806B1 (cg-RX-API-DMAC10.html)
JP (2) JP6473274B1 (cg-RX-API-DMAC10.html)
KR (2) KR102083253B1 (cg-RX-API-DMAC10.html)
CN (2) CN110913867B (cg-RX-API-DMAC10.html)
AU (1) AU2018257301B2 (cg-RX-API-DMAC10.html)
BR (1) BR112019018368B1 (cg-RX-API-DMAC10.html)
CA (1) CA3025567C (cg-RX-API-DMAC10.html)
ES (1) ES2912289T3 (cg-RX-API-DMAC10.html)
MX (2) MX379302B (cg-RX-API-DMAC10.html)
MY (2) MY196565A (cg-RX-API-DMAC10.html)
PH (1) PH12019502335A1 (cg-RX-API-DMAC10.html)
RU (1) RU2710366C1 (cg-RX-API-DMAC10.html)
SG (1) SG11201909170QA (cg-RX-API-DMAC10.html)
TW (1) TWI733019B (cg-RX-API-DMAC10.html)
WO (1) WO2018199180A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202007977RA (en) * 2018-02-28 2020-09-29 Santen Pharmaceutical Co Ltd Ophthalmic composition comprising diquafosol and cationic polymer
TW202000196A (zh) * 2018-03-01 2020-01-01 日商石原產業股份有限公司 保存安定性優異之醫藥組成物
WO2020175525A1 (ja) * 2019-02-27 2020-09-03 参天製薬株式会社 ジクアホソルまたはその塩、ビニル系高分子およびセルロース系高分子を含有する眼科用組成物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003095924A (ja) 2001-07-16 2003-04-03 Wakamoto Pharmaceut Co Ltd 熱ゲル化人工涙液

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2125060C (en) * 1993-07-02 1999-03-30 Henry P. Dabrowski Ophthalmic solution for artificial tears
JP3450805B2 (ja) * 2000-08-08 2003-09-29 わかもと製薬株式会社 水性医薬組成物
GB0210794D0 (en) * 2002-05-10 2002-06-19 Chart Heat Exchangers Ltd Heat exchangers
JP4263456B2 (ja) 2002-03-18 2009-05-13 わかもと製薬株式会社 ヒアルロン酸含有熱ゲル化製剤
JP4263418B2 (ja) * 2002-03-18 2009-05-13 わかもと製薬株式会社 熱ゲル化人工涙液
EP1681065A4 (en) 2003-10-31 2011-12-28 Wakamoto Pharma Co Ltd WATER-BASED COMPOSITION SUBJECTED TO REVERSIBLE THERMOREGULATION
JP5649261B2 (ja) * 2004-05-07 2015-01-07 ロート製薬株式会社 高粘度点眼剤
JP5661981B2 (ja) * 2004-11-26 2015-01-28 大正製薬株式会社 眼科用剤
CN101784287B (zh) * 2007-06-26 2013-04-24 若素制药株式会社 水性组合物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003095924A (ja) 2001-07-16 2003-04-03 Wakamoto Pharmaceut Co Ltd 熱ゲル化人工涙液

Also Published As

Publication number Publication date
MX2018014935A (es) 2019-04-09
KR102281853B1 (ko) 2021-07-23
WO2018199180A1 (ja) 2018-11-01
EP3593806A4 (en) 2020-03-25
CN113332233B (zh) 2022-02-25
EP3593806B1 (en) 2022-03-30
JPWO2018199180A1 (ja) 2019-06-27
MX379302B (es) 2025-03-11
BR112019018368A2 (pt) 2020-04-07
MY196323A (en) 2023-03-24
KR20190110624A (ko) 2019-09-30
TW201842900A (zh) 2018-12-16
ES2912289T3 (es) 2022-05-25
RU2710366C1 (ru) 2019-12-26
PH12019502335A1 (en) 2020-09-14
JP6473274B1 (ja) 2019-02-20
CN113332233A (zh) 2021-09-03
AU2018257301A1 (en) 2019-08-22
KR20200020999A (ko) 2020-02-26
JP6736705B2 (ja) 2020-08-05
BR112019018368B1 (pt) 2021-03-02
CN110913867B (zh) 2021-06-11
US20180360746A1 (en) 2018-12-20
MY196565A (en) 2023-04-19
JP2019104740A (ja) 2019-06-27
CA3025567C (en) 2019-10-22
US20200121592A1 (en) 2020-04-23
AU2018257301B2 (en) 2019-10-31
CN110913867A (zh) 2020-03-24
US11096889B2 (en) 2021-08-24
SG11201909170QA (en) 2019-11-28
TWI733019B (zh) 2021-07-11
CA3025567A1 (en) 2018-11-01
EP3593806A1 (en) 2020-01-15
US10532026B2 (en) 2020-01-14

Similar Documents

Publication Publication Date Title
JP6452283B2 (ja) 眼の異物感改善剤
EP3213763B1 (en) Ophthalmic composition comprising cyclosporine and trehalose
KR20220052971A (ko) 디쿠아포솔 또는 그 염 및 폴리비닐피롤리돈을 함유하는 수성 안과용 조성물
JP2021178845A (ja) 眼科組成物
KR20200020999A (ko) 열겔화 인공 누액
JP2024166367A (ja) 眼科組成物
JP2018177820A (ja) 水性眼科組成物
KR102268002B1 (ko) 효과 지속성 점안제 조성물
JP7206078B2 (ja) 摩擦によるストレス低減剤
HK40017178A (en) Thermogelling artificial tears
HK40017178B (en) Thermogelling artificial tears
BR112019021917A2 (pt) Composições de iodo

Legal Events

Date Code Title Description
A201 Request for examination
A302 Request for accelerated examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PA0302 Request for accelerated examination

St.27 status event code: A-1-2-D10-D17-exm-PA0302

St.27 status event code: A-1-2-D10-D16-exm-PA0302

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

A107 Divisional application of patent
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20230226

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20230226